Chemoinformaics analysis of 10-bromo-7-hydroxy-11-iodolaurene
| Molecular Weight | 421.116 | nRot | 1 |
| Heavy Atom Molecular Weight | 402.972 | nRig | 12 |
| Exact Molecular Weight | 419.959 | nRing | 2 |
| Solubility: LogS | -5.917 | nHRing | 0 |
| Solubility: LogP | 5.088 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 46.2543 |
| nHD | 1 | BPOL | 23.1177 |
| QED | 0.482 |
| Synth | 4.164 |
| Natural Product Likeliness | 1.519 |
| NR-PPAR-gamma | 0.955 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.234 |
| Pgp-sub | 0 |
| HIA | 0.086 |
| CACO-2 | -4.692 |
| MDCK | 0.0000194 |
| BBB | 0.631 |
| PPB | 0.986651 |
| VDSS | 3.443 |
| FU | 0.0215668 |
| CYP1A2-inh | 0.921 |
| CYP1A2-sub | 0.898 |
| CYP2c19-inh | 0.565 |
| CYP2c19-sub | 0.768 |
| CYP2c9-inh | 0.583 |
| CYP2c9-sub | 0.837 |
| CYP2d6-inh | 0.601 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.469 |
| CYP3a4-sub | 0.474 |
| CL | 5.732 |
| T12 | 0.136 |
| hERG | 0.009 |
| Ames | 0.02 |
| ROA | 0.47 |
| SkinSen | 0.536 |
| Carcinogencity | 0.064 |
| EI | 0.92 |
| Respiratory | 0.922 |
| NR-Aromatase | 0.455 |
| Antiviral | Yes |
| Prediction | 0.653014 |